Ara-290 (16 mg Vial)
Reconstitution and handling reference for Ara-290 (16 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.
CAT No:
CAS No:
Synonyms/Alias:Ara-290
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Reconstitution and handling reference for Ara-290 (16 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.
Quickstart
Reconstitute: Add 2.0 mL bacteriostatic water → 8 mg/mL concentration.
Target dose: 4 mg once daily subcutaneously (after initial 2 mg titration).
Easy measuring: At 8 mg/mL, 1 unit = 0.01 mL = 80 mcg on a U-100 insulin syringe.
Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); reconstituted: refrigerate and use within 28 days.
Notes
Practical considerations for consistency and safety. Use a new sterile insulin syringe for each injection; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [8]. Inject slowly; wait a few seconds before withdrawing the needle. Document daily dose and injection site to maintain consistency. No clinically significant adverse effects were reported at 4 mg/day in 28-day clinical trials [3].
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Ara-290, 16 mg each): 8 weeks ≈ 14 vials
12 weeks ≈ 21 vials
16 weeks ≈ 28 vials
Insulin Syringes (U-100): Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution. 8 weeks (14 vials): 28 mL → 3 × 10 mL bottles
12 weeks (21 vials): 42 mL → 5 × 10 mL bottles
16 weeks (28 vials): 56 mL → 6 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China